160 related articles for article (PubMed ID: 27356686)
1. Hypermethylation Status of E-Cadherin Gene in Gastric Cancer Patients in a High Incidence Area.
Rashid H; Alam K; Afroze D; Yousuf A; Banday M; Kawoosa F
Asian Pac J Cancer Prev; 2016; 17(6):2757-60. PubMed ID: 27356686
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.
Graziano F; Arduini F; Ruzzo A; Mandolesi A; Bearzi I; Silva R; Muretto P; Testa E; Mari D; Magnani M; Scartozzi M; Cascinu S
Ann Oncol; 2004 Mar; 15(3):489-92. PubMed ID: 14998854
[TBL] [Abstract][Full Text] [Related]
3. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
[TBL] [Abstract][Full Text] [Related]
4. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
[TBL] [Abstract][Full Text] [Related]
5. Comparison of CDH1 Gene Hypermethylation Status in Blood and Serum among Gastric Cancer Patients.
Li Z; Guo Z
Pathol Oncol Res; 2020 Apr; 26(2):1057-1062. PubMed ID: 30989488
[TBL] [Abstract][Full Text] [Related]
6. Role of hMLH1 and E-cadherin promoter methylation in gastric cancer progression.
Moghbeli M; Moaven O; Memar B; Raziei HR; Aarabi A; Dadkhah E; Forghanifard MM; Manzari F; Abbaszadegan MR
J Gastrointest Cancer; 2014 Mar; 45(1):40-7. PubMed ID: 24022108
[TBL] [Abstract][Full Text] [Related]
7. Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer.
Graziano F; Arduini F; Ruzzo A; Bearzi I; Humar B; More H; Silva R; Muretto P; Guilford P; Testa E; Mari D; Magnani M; Cascinu S
Clin Cancer Res; 2004 Apr; 10(8):2784-9. PubMed ID: 15102685
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil.
Leal M; Lima E; Silva P; Assumpção P; Calcagno D; Payão S; Burbano RR; Smith M
World J Gastroenterol; 2007 May; 13(18):2568-74. PubMed ID: 17552003
[TBL] [Abstract][Full Text] [Related]
10. CDH1 gene promoter hypermethylation in gastric cancer: relationship to Goseki grading, microsatellite instability status, and EBV invasion.
Zazula M; Ferreira AM; Czopek JP; Kolodziejczyk P; Sinczak-Kuta A; Klimkowska A; Wojcik P; Okon K; Bialas M; Kulig J; Stachura J
Diagn Mol Pathol; 2006 Mar; 15(1):24-9. PubMed ID: 16531765
[TBL] [Abstract][Full Text] [Related]
11. [Gastric carcinoma and chronic gastritis: epigenetic regulation of CDH1 (E-Cadherin), CDKN2A (p16INK4A), PTGS2 (COX-2) and EGFR genes through methylation].
Silva M; Azenha D; Pereira C; Almeida A; Balseiro S; Sampaio AM; Santos P; Carvalho L
Acta Med Port; 2010; 23(1):5-14. PubMed ID: 20353702
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.
Corso G; Carvalho J; Marrelli D; Vindigni C; Carvalho B; Seruca R; Roviello F; Oliveira C
J Clin Oncol; 2013 Mar; 31(7):868-75. PubMed ID: 23341533
[TBL] [Abstract][Full Text] [Related]
13. Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis.
Jing H; Dai F; Zhao C; Yang J; Li L; Kota P; Mao L; Xiang K; Zheng C; Yang J
Medicine (Baltimore); 2014 Oct; 93(19):e107. PubMed ID: 25340495
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma.
Sudo M; Chong JM; Sakuma K; Ushiku T; Uozaki H; Nagai H; Funata N; Matsumoto Y; Fukayama M
Int J Cancer; 2004 Mar; 109(2):194-9. PubMed ID: 14750169
[TBL] [Abstract][Full Text] [Related]
15. [Frequent promoter hypermethylation of several tumor suppressor genes in gastric carcinoma and foveolar epithelium].
Cai JC; Liu D; Zhang HP; Zhong S; Xia NS
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):510-3. PubMed ID: 18069630
[TBL] [Abstract][Full Text] [Related]
16. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
[TBL] [Abstract][Full Text] [Related]
17. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL
Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596
[TBL] [Abstract][Full Text] [Related]
18. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.
Tamura G; Yin J; Wang S; Fleisher AS; Zou T; Abraham JM; Kong D; Smolinski KN; Wilson KT; James SP; Silverberg SG; Nishizuka S; Terashima M; Motoyama T; Meltzer SJ
J Natl Cancer Inst; 2000 Apr; 92(7):569-73. PubMed ID: 10749913
[TBL] [Abstract][Full Text] [Related]
19. Role of DNA methylation in the development of diffuse-type gastric cancer.
Yamamoto E; Suzuki H; Takamaru H; Yamamoto H; Toyota M; Shinomura Y
Digestion; 2011; 83(4):241-9. PubMed ID: 21273772
[TBL] [Abstract][Full Text] [Related]
20. Frequent promoter methylation of CDH1 in non-neoplastic mucosa of sporadic diffuse gastric cancer.
Lee KH; Hwang D; Kang KY; Lee S; Kim DY; Joo YE; Lee JH
Anticancer Res; 2013 Sep; 33(9):3765-74. PubMed ID: 24023308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
